Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.

Authors

Mira Jung, Arne Schmidt, Marida Sansonetti, Bashar Al Soodi, Sabrina Thum, Angelika Pfanne, Annette Just, Ke Xiao, Cheng-Kai Huang, Sergej Erschow, Melanie Ricke-Hoch, Lea Oehlsen, Wilson Agyapong, Karina Jansen, Jonas Blume, Gwen Büchler, Erika Hilbold, Christian Bär, Natalie Weber, Maximilian Schinke, Ariane Hai Ha Nguyen, Kai C Wollert, James T Thackeray, Frank Bengel, Nico Lachmann, Thomas Thum

Published in

European heart journal. Volume 47. Issue 22. Pages 2831-2847. Jun 09, 2026.

Abstract

Cardiac remodelling following MI is intricately linked to macrophage polarization dynamics, yet the underlying mechanisms remain incompletely elucidated. In this study, circHIPK2, a novel circRNA, was identified as being upregulated in inflammatory cardiac macrophages following MI. Its expression correlated with post-MI inflammation dynamics, suggesting a regulatory role in macrophage polarization. It was hypothesized that circHIPK2 functions as a molecular switch of macrophage polarization during MI progression.
To test this hypothesis, circHIPK2 levels were modulated in vitro using siRNA and overexpression vectors. A murine MI model with macrophage-targeted inhibition of circHIPK2 through AAV9-mediated shRNA delivery was employed. Cardiac function was evaluated using echocardiography, histology, and PET imaging. An ex vivo co-culture platform incorporating living myocardial slices from heart failure patients and circHIPK2-modulated human iPSC-derived macrophages was established to explore a translational potential.
CircHIPK2 interacts with its binding partner G3BP1 to promote stress granule formation in macrophages. This interaction initiates a downstream inflammatory cascade, highlighting its role in immune regulation. Inhibition of circHIPK2 suppressed inflammatory signalling and reduced pro-inflammatory cytokine secretion. In a mouse model of MI, macrophage-specific inhibition of circHIPK2 improved cardiac function, reshaped the inflammatory environment, and attenuated fibrosis progression. Silencing circHIPK2 in human macrophages demonstrated therapeutic potential in established heart failure, promoting beneficial cardiac healing.
Targeting circHIPK2 in macrophages may represent a promising therapeutic strategy for treating inflammatory cardiac conditions and heart failure, potentially leading to the development of RNA-based therapies targeting immune cells in MI treatment.

PMID:
41667113
Bibliographic data and abstract were imported from PubMed on 13 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.